TrialClinical drug investigation2011

Safety, tolerability and pharmacokinetics of dalcetrapib following single and multiple ascending doses in healthy subjects: a randomized, double-blind, placebo-controlled, phase I study.

Michael Derks et al.PubMed ↗Publisher ↗

No numbers read from the abstract.